Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the arthrogryposis market grown in recent years?

The size of the arthrogryposis market has seen robust growth in the past few years. Its valuation is expected to climb from $0.93 billion in 2024 to $0.98 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.8%. This significant growth observed in the historic period is primarily due to factors such as an increase in osteoarthritis cases, a rise in sports-related injuries, a growing elderly population, a rise in sedentary habits, and heightened awareness about osteoarthritis therapeutic options.

How is the arthrogryposis market size expected to evolve during the forecast period?

The market size for arthrogryposis is predicted to experience robust growth in the forthcoming years. With a compound annual growth rate (CAGR) of 5.5%, it is forecasted to reach $1.22 billion by 2029. The expansion within this period can be ascribed to factors like the surging elderly population, heightened use of pain relief drugs, an uptick in sports-related injuries, an increased pervasiveness of osteoarthritis, and a rising population at risk of osteoarthritis. Predicted trends for the forecast period encompass progress in the realm of medical technology, pioneering work in genetic research, technological progress within treatment alternatives, the advent of non-invasive therapies, and progression within the field of biologics and stem cell therapies.

Get your arthrogryposis market report here!

https://www.thebusinessresearchcompany.com/report/arthrogryposis-global-market-report

Which key drivers are propelling the arthrogryposis market’s growth?

The surge in congenital disorders is predicted to stimulate the expansion of the arthrogryposis market. Congenital disorders are irregularities present at birth, either structural or functional and originate during fetal development. The escalating incidence of these disorders is linked to elements like enhanced prenatal diagnostics, environmental influences, genetic mutations, and alterations in lifestyle. Arthrogryposis contributes to our comprehension of these disorders by emphasizing the significance of fetal movement, genetic elements, and neuromuscular development in musculoskeletal anomalies. For example, as per the World Health Organization in February 2023, each year, around 240,000 newborns globally fail to survive congenital disorders within the initial 28 days post-birth. Moreover, congenital conditions account for an estimated 170,000 deaths among children between 1 month and 5 years. Therefore, the growing incidence of congenital disorders is augmenting growth in the arthrogryposis market. The Influx Of Growing Telehealth Services And Its Impact On The Market Growth

What are the market segments in the arthrogryposis industry?

The arthrogryposis market covered in this report is segmented –

1) By Type: Classic Arthrogryposis, Distal Arthrogryposis, Amyoplasia

2) By Treatment Type: Occupational Therapists, Physical Therapy, Surgery, Imaging Diagnostics, CT Scan

3) By Patient Age: Children, Adults, Elderly

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

Subsegments:

1) By Classic Arthrogryposis: Multiple Joint Involvement, Flexion Contractures, Severe Muscle Weakness, Progressive Arthrogryposis, Intellectual Impairment

2) By Distal Arthrogryposis: Isolated Limb Involvement, Contractures of Hands and Feet, Distal Joint Contractures, Autosomal Dominant Inheritance

3) By Amyoplasia: Severe Limb Contractures, Muscle Hypotonia (low muscle tone), No Cognitive Impairment, Symmetric Joint Involvement, Lack Of Muscle Development In Affected Limbs

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21105&type=smp

Which leading companies are shaping the growth of the arthrogryposis market?

Major companies operating in the arthrogryposis market are Hitachi Ltd., The Cleveland Clinic Foundation, The Johns Hopkins Health System Corporation, NYU Langone Hospitals, Seattle Children’s Hospital, Boston Children’s Hospital, Phoenix Children’s Hospital Inc., Children’s Healthcare of Atlanta Inc., The Nemours Foundation, Shriners Hospitals for Children, Hanger Inc., Texas Scottish Rite Hospital for Children, Gillette Children’s Specialty Healthcare, Paley Orthopedic & Spine Institute LLC, Quantum Rehab a division of Pride Mobility Products Corp., Obi Robot Inc., Gammie HomeCare LLC, Prothotic Laboratories Inc., SSM Health Cardinal Glennon Children’s Hospital, Arthrogryposis Multiplex Congenita Support Inc.

What are the key trends shaping the future of the arthrogryposis market?

Key businesses in the arthrogryposis market are centering their focus on the progression of surgical procedures such as carpal wedge osteotomy to enhance joint flexibility and mitigate contractures. This is targeted at delivering improved functional results to the patients and uplifting their life quality. In medical terms, carpal wedge osteotomy is a surgery characterized by the excision of a wedge-like bone segment from the wrist to rectify joint distortions and boost hand performance in arthrogryposis patients. For instance, Akron Children’s Hospital, a pediatric acute care facility based in the United States, devised a novel method in November 2022. This novel method is a combination of carpal wedge osteotomy and flexor-pronator slide, constructed with the ultimate aim of improving joint flexibility for patients tormented by this uncommon condition with symptoms of rigidity or contracted joints.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21105

Which geographic areas are influencing the growth of the arthrogryposis market?

North America was the largest region in the arthrogryposis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arthrogryposis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Antispasmodics Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antispasmodics-drugs-global-market-report

Glycopeptide Antibiotics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/glycopeptide-antibiotics-global-market-report

Multiple Myeloma Drugs Global Market Report 2025

https://thebusinessresearchcompany.com/report/multiple-myeloma-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: